Previous 10 | Next 10 |
NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP, “Indaptus” or “the Company”), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announces that the American Association f...
NEW YORK, March 13, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP, “Indaptus” or “the Company”), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announces that Atlanta, Ga.-based Emory W...
NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP, “Indaptus” or “the Company”), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announces the dosing of the first subject...
NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP, “Indaptus” or “the Company”), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announces it has named Robert Martell, M.D...
NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP, “Indaptus” or “the Company”), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announces the addition of Morristown Medic...
Intec Closes Merger with Decoy Biosystems Completes $30 Million Private Placement Changes Corporate Name to Indaptus Therapeutics to Reflect Clinical Focus PR Newswire NEW YORK , Aug. 3, 2021 /PRNewswire/ -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("In...
Intec Announces Expected Closing Date of Decoy Merger PR Newswire JERUSALEM , Aug. 3, 2021 /PRNewswire/ -- Intec Parent , Inc. (NASDAQ: NTEC) (" Intec Parent " or the "Company"), today announced that the pending and previously announced reverse merger (th...
Gainers: ERYTECH Pharma (NASDAQ:ERYP) +64%. Allied Healthcare Products (NASDAQ:AHPI) +49%. iFresh (NASDAQ:IFMK) +35%. Marin Software Incorporated (NASDAQ:MRIN) +29%. Atlassian Corporation (NASDAQ:TEAM) +24%. Xiaobai Maimai (NASDAQ:HX) +18%. First High-School Education (NYSE:FHS) +16%. Bridgel...
Gainers: ERYTECH Pharma (NASDAQ:ERYP) +84%, Allied Healthcare Products (NASDAQ:AHPI) +31%, SCWorx (NASDAQ:WORX) +18%, Veracyte (NASDAQ:VCYT) +13%, Misonix (NASDAQ:MSON) +11%. Losers: Intec Pharma (NASDAQ:NTEC) -20%, Translate Bio (NASDAQ:TBIO) ...
Pinterest (NYSE:PINS) -20% on Q2 earnings release Cassava Sciences (NASDAQ:SAVA) -17% despite presenting 'positive' data on simufilam for Alzheimer's 360 DigiTech (NASDAQ:QFIN) -12%. Annovis Bio (NYSE:ANVS) -11%. Uxin (NASDAQ:UXIN) -11% on Q4 earnings release. Le...
News, Short Squeeze, Breakout and More Instantly...
Intec Pharma Ltd. Company Name:
NTEC Stock Symbol:
NASDAQ Market:
- Chief Scientific Officer Dr. Newman to present initial clinical data that further validates Company’s “Pulse-Prime” hypothesis - Dr. Newman also named Chair of the Summit NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a...
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced that its Chief Medical Officer, Roger Waltzman, M.D., will present an update on ...
Latest data from first and second cohorts support Company’s 'pulse-prime' approach, demonstrating rapid clearance, broad immune activation, and encouraging safety profile Poster Presented at American Society of Clinical Oncology Annual Meeting NEW YORK, June 03, 2024 (GLOBE...